Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Use drugs before percutaneous transluminal coronary angioplasty
| The first 150 words of the full text of this article appear below. |
Angina pectoris is a common manifestation of
coronary artery disease. Effective treatment was not available until
Brunton introduced nitrate of amyl in 1867.1 Drugs for the
treatment of chronic angina became available much later, first the long acting nitrates,
blockers in the 1960s, and calcium antagonists in
the 1970s. At the same time, bypass surgery and, later, percutaneous transluminal coronary angioplasty were introduced.
In this issue of the BMJ Bucher and colleagues report a
meta-analysis of randomised controlled trials comparing percutaneous transluminal coronary angioplasty and medical treatment for non-acute coronary artery disease (p 73).2 The treatment of stable
angina aims to reduce chest pain and prevent cardiovascular
events.
1 3
Bypass surgery is more effective than
medical treatment, at least according to trials carried out in the
1970s, but it is expensive, is associated with morbidity and mortality,
and needs patients to stay longer in hospital.3
Percutaneous transluminal coronary angioplasty can
Read all Rapid Responses